Literature DB >> 10693547

Posterolateral and anterior interbody spinal fusion models in the sheep.

T Steffen1, D Marchesi, M Aebi.   

Abstract

Posterolateral and anterior interbody spinal arthrodesis is a frequent procedure, but high nonunion rates are reported and harvesting autologous bone graft from the iliac crest significantly increases morbidity. Bone graft substitutes are an alternative, but to date clinical results are not conclusive. Bone substitutes can be organic or inorganic, biologic or synthetic. They can have osteoconductive properties, inductive properties or both. Animal experiments are essential to investigating bone substitutes using biomechanical and histologic methods not available in clinical studies. Few authors reported on instrumented anterior fusion models, but none used the sheep model. In the current study posterolateral and anterior interbody fusion models in sheep are described. Both models used instrumented fusions, applying porous mineral scaffolds, alone or mixed with bone. The surgical techniques are described step-by-step and potential difficulties are highlighted. Preliminary results are reported for the posterolateral fusion model using coralline graft substitutes. The coral granules mixed with locally harvested bone had fusion outcomes similar to pure autologous bone. The graft substitute showed marked resorption between 12 and 20 weeks. All fusions had bone cortex and good trabecular connectivity. Histologic evaluation suggests after 20 weeks nearly the entire surface of the substitute is covered with new bone. Porous mineral bone substitutes mixed with locally harvested autologous bone are thought to be a valid alternative for posterolateral fusions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10693547     DOI: 10.1097/00003086-200002000-00004

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  7 in total

1.  Surgical anatomy, transperitoneal approach, and early postoperative complications of a ventral lumbar spine surgical model in Lewis rats.

Authors:  Sheela R Damle; Agata Krzyzanowska; Robert J Frawley; Matthew E Cunningham
Journal:  Comp Med       Date:  2013-10       Impact factor: 0.982

2.  [Radiological comparison between two procedures for ventral spondylodesis: autologous iliac crest bone graft vs bovine bone graft].

Authors:  D Kubosch; J Rohr; K Izadpanah; T O Hammer; N P Südkamp; P C Strohm
Journal:  Unfallchirurg       Date:  2012-10       Impact factor: 1.000

3.  Nell-1 protein promotes bone formation in a sheep spinal fusion model.

Authors:  Ronald K Siu; Steven S Lu; Weiming Li; Julie Whang; Gabriel McNeill; Xinli Zhang; Benjamin M Wu; A Simon Turner; Howard B Seim; Paul Hoang; Jeffrey C Wang; Arthur A Gertzman; Kang Ting; Chia Soo
Journal:  Tissue Eng Part A       Date:  2011-02-08       Impact factor: 3.845

4.  Efficacy of silicate-substituted calcium phosphate with enhanced strut porosity as a standalone bone graft substitute and autograft extender in an ovine distal femoral critical defect model.

Authors:  Stacy A Hutchens; Charlie Campion; Michel Assad; Madeleine Chagnon; Karin A Hing
Journal:  J Mater Sci Mater Med       Date:  2015-12-18       Impact factor: 3.896

5.  Anterior lumbar interbody fusion with carbon fiber cage loaded with bioceramics and platelet-rich plasma. An experimental study on pigs.

Authors:  Haisheng Li; Xuenong Zou; Qingyun Xue; Niels Egund; Martin Lind; Cody Bünger
Journal:  Eur Spine J       Date:  2004-01-17       Impact factor: 3.134

6.  Assessing the stiffness of spinal fusion in animal models.

Authors:  Jocelyn M Cottrell; Marjolein C H van der Meulen; Joseph M Lane; Elizabeth R Myers
Journal:  HSS J       Date:  2006-02

7.  The fusion rate of demineralized bone matrix compared with autogenous iliac bone graft for long multi-segment posterolateral spinal fusion.

Authors:  Tsai-Sheng Fu; I-Chun Wang; Meng-Ling Lu; Ming-Kai Hsieh; Lih-Huei Chen; Wen-Jer Chen
Journal:  BMC Musculoskelet Disord       Date:  2016-01-05       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.